OC
IDXX icon

Oarsman Capital’s Idexx Laboratories IDXX Stock Holding History

Oarsman Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Sell
494
-99
-17% -$55.5K 0.03% 207
2026
Q1 		$333K Buy
593
+165
+39% +$106K 0.04% 168
2025
Q4 		$290K Sell
428
-47
-10% -$32K 0.04% 183
2025
Q3 		$303K Buy
475
+3
+0.6% +$1.82K 0.04% 178
2025
Q2 		$253K Buy
+472
New +$226K 0.04% 206
2025
Q1 		– Sell
-446
Closed -$184K – 522
2024
Q4 		$184K Sell
446
-43
-9% -$18.9K 0.03% 244
2024
Q3 		$247K Hold
489
– – 0.05% 212
2024
Q2 		$238K Hold
489
– – 0.05% 203
2024
Q1 		$264K Hold
489
– – 0.06% 192
2023
Q4 		$271K Buy
+489
New +$230K 0.07% 183

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Oarsman Capital's IDXX Position: Q2 2026 in Review

Oarsman Capital reduced its Idexx Laboratories (IDXX) stake by 17% in Q2 2026, selling an estimated $55.5K and leaving 494 shares worth $260K. The position accounts for 0.03% of the portfolio, ranked #207.

Oarsman Capital first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $333K in Q1 2026. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Oarsman Capital held 494 shares of Idexx Laboratories worth $260K as of Q2 2026.
  • Oarsman Capital sold 99 Idexx Laboratories shares in Q2 2026, an estimated $55.5K.
  • Idexx Laboratories made up 0.03% of Oarsman Capital's portfolio in Q2 2026, its #207 holding.
  • Oarsman Capital first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
  • Oarsman Capital's Idexx Laboratories position peaked at $333K in Q1 2026.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Oarsman Capital's 13F filing for Q2 2026, filed 7 Aug 2026.